![Orgenesis Inc. logo](/logos/ORGS.webp)
Orgenesis Inc.
NASDAQ:ORGS
Overview | Financials
Company Name | Orgenesis Inc. |
Symbol | ORGS |
Currency | USD |
Price | 0.59 |
Market Cap | 27,686,281 |
Dividend Yield | 0% |
52-week-range | 0.25 - 1.08 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Ms. Vered Caplan M.Sc. |
Website | https://www.orgenesis.com |
An error occurred while fetching data.
About Orgenesis Inc.
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD